Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trialMark T. Drayson, Janet Dunn, Jill Wood et al.|The Lancet Oncology|2019Cited by 160
Guidelines for screening and management of late and long‐term consequences of myeloma and its treatmentJohn A. Snowden, David Greenfield, Jennifer M. Bird et al.|British Journal of Haematology|2017Cited by 64
Time to redefine MyelomaGuy Pratt, Jenny Bird, Stella Bowcock et al.|British Journal of Haematology|2015Cited by 17
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trialCatherine Atkin, Gulnaz Iqbal, Tim Planche et al.|British Journal of Haematology|2020Cited by 9